SEC FORM 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0287
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person ^*

Hussain Aamir

(Last)

(First)

(Middle)

1550 WEWATTA STREET

SUITE 800

(Street)

DENVER

80202

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Liberty Latin America Ltd. [ LILA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP, CT&PO

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Preference Shares	06/16/2026		J	V	60,770	A	$ 0	60,770 ⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Share Units P	⁽²⁾	06/17/2026		J	V	7,086 ⁽³⁾		⁽⁴⁾	⁽⁴⁾	Series A Preference Shares	7,086 ⁽³⁾	$ 0	7,086	D
Restricted Share Units P	⁽²⁾	06/17/2026		J	V	13,458 ⁽³⁾		⁽⁵⁾	⁽⁵⁾	Series A Preference Shares	13,458 ⁽³⁾	$ 0	13,458	D
Restricted Share Units P	⁽²⁾	06/17/2026		J	V	17,419 ⁽³⁾		⁽⁶⁾	⁽⁶⁾	Series A Preference Shares	17,419 ⁽³⁾	$ 0	17,419	D
Share Appreciation Rights A	$ 7.52							⁽⁷⁾	04/18/2032	Class A Common Shares	148,854 ⁽⁸⁾		148,854	D
Share Appreciation Rights C	$ 7.28							⁽⁷⁾	04/18/2032	Class C Common Shares	306,036 ⁽⁹⁾		306,036	D
Share Appreciation Rights A	$ 7.52							⁽⁷⁾	04/19/2032	Class A Common Shares	143,000 ⁽¹⁰⁾		143,000	D
Share Appreciation Rights C	$ 7.28							⁽⁷⁾	04/19/2032	Class C Common Shares	294,000 ⁽¹¹⁾		294,000	D
Share Appreciation Rights A	$ 5.47							⁽⁷⁾	03/20/2033	Class A Common Shares	154,650 ⁽¹²⁾		154,650	D
Share Appreciation Rights C	$ 5.3							⁽⁷⁾	03/20/2033	Class C Common Shares	317,952 ⁽¹³⁾		317,952	D
Share Appreciation Rights A	$ 4.31							⁽¹⁴⁾	03/12/2034	Class A Common Shares	191,803 ⁽¹⁵⁾		191,803	D
Share Appreciation Rights C	$ 4.24							⁽¹⁴⁾	03/12/2034	Class C Common Shares	394,336 ⁽¹⁶⁾		394,336	D
Share Appreciation Rights A	$ 4.68							⁽¹⁷⁾	03/14/2035	Class A Common Shares	177,272 ⁽¹⁸⁾		177,272	D
Share Appreciation Rights C	$ 4.54							⁽¹⁷⁾	03/14/2035	Class C Common Shares	364,461 ⁽¹⁹⁾		364,461	D
Share Appreciation Rights A	$ 5.31							⁽²⁰⁾	03/13/2036	Class A Common Shares	156,951 ⁽²¹⁾		156,951	D
Share Appreciation Rights C	$ 5.29							⁽²⁰⁾	03/13/2036	Class C Common Shares	322,682 ⁽²²⁾		322,682	D

Explanation of Responses:

1. On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 60,770 Preferred Shares.

2. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.

3. In connection with the Dividend, all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

4. The Restricted Share Units vest in full on March 15, 2027.

5. The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.

6. The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.

7. The derivative security is fully vested.

8. This share appreciation right award ("SAR") was previously reported as a SAR relating to 104,094 shares of the Issuer's common stock at a base price of $10.75 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

9. This share appreciation right award ("SAR") was previously reported as a SAR relating to 208,188 shares of the Issuer's common stock at a base price of $10.70 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

10. This share appreciation right award ("SAR") was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $10.75 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

11. This share appreciation right award ("SAR") was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $10.70 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

12. This share appreciation right award ("SAR") was previously reported as a SAR relating to 108,147 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

13. This share appreciation right award ("SAR") was previously reported as a SAR relating to 216,294 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

14. The SARs vest in full on March 15 2027.

15. This share appreciation right award ("SAR") was previously reported as a SAR relating to 134,128 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

16. This share appreciation right award ("SAR") was previously reported as a SAR relating to 268,256 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

17. The SARs vest in two equal annual installments on March 15 of 2027 and 2028.

18. This share appreciation right award ("SAR") was previously reported as a SAR relating to 123,967 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

19. This share appreciation right award ("SAR") was previously reported as a SAR relating to 247,933 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

20. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.

21. This share appreciation right award ("SAR") was previously reported as a SAR relating to 109,756 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

22. This share appreciation right award ("SAR") was previously reported as a SAR relating to 219,512 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Remarks:

The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP.

	/s/ John M. Winter, Attorney-in-Fact	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.